Cytokine Reducing Effect of Azelnidipine in Human Peripheral Blood Mononuclear Cells-Reference-Cited by-同舟云学术

Cytokine Reducing Effect of Azelnidipine in Human Peripheral Blood Mononuclear Cells

Published:2010 Issue:7 Volume:33 Page:1148-1151
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Miura Ryuzea¹,Nakamura Kazufumi¹,Miura Daiji¹²,Miura Aya¹,Kajiya Masahito¹,Hisamatsu Kenichi¹,Nagase Satoshi¹,Morita Hiroshi¹,Kusano Kengo Fukushima¹,Matsubara Hiromi³,Ohe Tohru²,Ito Hiroshi¹

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University

2. Department of Cardiovascular Medicine, The Sakakibara Heart Institute of Okayama

3. Division of Cardiology, National Hospital Organization Okayama Medical Center

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/33/7/33_7_1148/_pdf

Reference45 articles.

1. Atherosclerosis — An Inflammatory Disease

2. Molecular and cellular interface between behavior and acute coronary syndromes

3. Vascular Inflammation and the Renin-Angiotensin System

4. Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

5. Epoprostenol Therapy Decreases Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Primary Pulmonary Hypertension

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy;Biomolecules;2021-05-10

2. Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study);Diabetology & Metabolic Syndrome;2015-09-17

3. Hydrolyzed tilapia fish collagen modulates the biological behavior of macrophages under inflammatory conditions;RSC Advances;2015

4. Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders;Expert Review of Cardiovascular Therapy;2014-12